Indivior expects the attackers to attack at an annual rally this week after a London drug dealer withheld bonuses from their former boss, even though he was arrested due to US harassment.
Shaun Thaxter, a former superintendent, was sentenced to six months in prison last year and agreed to pay a fine and confiscate $ 600,000 later. admitting guilt an error causing the company to share false and misleading information about the safety of Suboxone Film with a government official. These drugs are used to treat opioid addiction.
Shareholders and senior advisers challenged the company’s decision to retain the reward given to the Thaxter in accordance with their long-term security plan, despite the fact that it was given to Indivior from lawsuits.
Institutional Shareholder Services and Glass Lewis, a support group, have urged investors to vote against the company’s report, questioning why Indivior did not use malus and clawbacks, which allow businesses to reduce or restrict bonuses or force managers to return them. events.
According to the ISS, Thaxter left the company with more than 1m in special divisions, more than $ 1.5m, which do not pay until 2022 and 2023.
The ISS said: “As the leading business leader since 2009, Shaun Thaxter has been held accountable for the financial and reputation of the company for the misuse of Suboxone.”
The top 20 participants also opposed the adoption committee’s decision to have Thaxter be seen as a “donor” and to maintain the prize even while in prison.
The program of US opioid epidemic has claimed nearly half a million lives in the last 20 years, according to the U.S. Centers for Disease Control and Prevention, when more Americans began taking drugs and then taking illegal drugs. The U.S. Department of Justice, state attorneys, and local opioid-producing companies are hoping to repay medical and legal debts for failing to comply.
Indivior said the remuneration committee was determined to allow him to continue his LTIP award “based on Mr. Thaxter’s leadership which has resulted in years of success and efficiency, as well as the absence of any wrongdoing or negligence”.
Suboxone Film, which contains buprenorphine and naloxone, was developed to treat opioid addiction. The Department of Justice reprimanded Thaxter for asking his colleagues to set up drug trafficking mechanisms with MassHealth, a Massachusetts superintendent. Some staff members shared false and false protections about the immediate danger to children.
MassHealth has since announced that it will provide access to treatment for patients with children under the age of six, who have received Medicaid, a US-funded program for low-income low-income insurance.
Thaxter has not been charged with felony criminal mischief for MassHealth. Wick Sollers, Thaxter’s lawyer, said: “We believe that the fact that Thaxter should be treated as a ‘good advertiser’ was completely justified in his case, which confirmed that he was unaware of any wrongdoing and agreed to correct it after taking action.”
Thaxter is one of the few drug lords to have ever been imprisoned on charges of opioid addiction. He led the company from 2009 to last year, shortly before pleading guilty, including when he was a member of Reckitt Benckiser.
Reckitt paid $ 1.4bn in 2019 to end their role in the US in the promotion of Suboxone. Indivior and his company Indivior Solutions also agreed to pay $ 600m to address some of the issues.
Thaxter paid a total of $ 2.1m in 2019, as well as $ 557,300 in 2020. Leaving June 2020, he received more than $ 1m in lieu of pay and benefits to cover his 12-month contract.
The ISS also advised shareholders to vote against the appointment of a remuneration committee, challenging “the company’s view of Thaxter as a good advertiser… Raises serious questions about its independence and judgment”.